TLR5 and breast carcinoma: Additionally, TLR5 agonist flagellin has been found to inhibit the cell state of activation and induce autophagy, and the autophagy protein MAP1S (Microtubule Associated Protein 1S) has been shown to regulate the flagellin/TLR5 signaling pathway in breast cancer cells (68, 69).